# AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
> **ANDA202239** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2012-09-05
## Drug
- **FDA Application Number:** ANDA202239
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
- **Generic name:** AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE
- **Active ingredients:** AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** Rising Pharma Holdings, Inc.
- **First approval:** 2012-09-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202239)
---
*AI Analytics · CC0 1.0*